Research
RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy
-
* Corresponding author: Yi-Long Wu syylwu@live.cn
Journal of Hematology & Oncology 2010, 3:10 doi:10.1186/1756-8722-3-10
No comments have yet been made on this article.